Surge in Dengue Fever in Low Income Nations Creating Opportunities for Expansion of Dengue Vaccines Market Demand: FMI

Jun 5, 2021

Growing demand for low cost vaccine for dengue along with consistently rising focus on innovation and clinical trials drives sales in the market.

Dubai, United Arab Emirates - June 5, 2021 /MarketersMedia/ —

The global dengue vaccines market is anticipated to cross the valuation of US$ 1 Bn by the end of 2031, as per a study by Future Market Insights (FMI). Rising focus on launching novel and more effective treatment for dengue will underpin growth in the market.

As per the World Health Organization (WHO), a steep rise in incidence of dengue is observed over the past decade. The actual numbers of global cases are under reported, however, one model estimated 390 million dengue virus infections per year, states the report.

To Get Sample Copy of Report Visit @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1763

Alarming increase of dengue cases registered worldwide will keep the demand for dengue vaccines high through the forecast period. Government initiatives undertaken to curb the incidence will provide tailwinds to growth registered.

Increase in cases of dengue and malaria in South Asian countries with low per capita income and limited spending on healthcare is observed over the past years.

Growing government assistance towards development of dengue medication and rising international pressure towards eradication of the infection will boost the market sales, finds ESOMAR-certified consulting firm Future Market Insights in this study.

For instance, India-based Serum Institute started a clinical trial in 2017 for validating the efficiency of its new dengue vaccine “VIS513 monoclonal antibody” aimed to treat dengue infections throughout the Indian subcontinent.

The company owns the exclusive licensing to the treatment and commercialization of drugs across the globe. The firm also invested around US$ 5 Mn, yielding US$ 34 million in gross profit upon completion of trial.

With surge in demand for dengue vaccines and growing government investment, promising growth is on the cards for the market.

“Countries in Asia are facing the increased burden of dengue infection due to lack of proper healthcare system and poor hygiene habits. Leading market players are investing in developing low cost vaccines to cater the huge demand in the Asia Pacific market,” remarks the FMI analyst. 

Key Takeaways

Increasing government and private funding on research and development of dengue vaccines and frequent outbreaks in union territories will provide lucrative growth opportunities in the U.S.
Dengue infection rate is expected to increase by more than 40% in next 50 years in Mexico, providing ideal conditions for the market growth in the country.
India is expected to be a lucrative market for the forecast period of 2021-2031. Growing awareness campaign related to hygiene and sanitization along with increasing government funding towards development of dengue vaccines are main market drivers in India.
Rapid expansion of cities, along with fluctuating climate conditions and extended wet periods led to rise in dengue infection rates. The surge in dengue infection has fueled the dengue vaccines market demand in Brazil.
Dengvaxia is the only FDA approved vaccine in the world with 76% efficacy in dengue prevention. New market players are trying to explore this high revenue opportunity.

For More Details, Ask Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-1763

Prominent Drivers

Rising prevalence of dengue in poor countries is accelerating the dengue vaccines market growth.
Poor habitable conditions and lack of proper sanitation in emerging economies are expected to fuel the market growth.
Rising government initiatives towards eradicating dengue on global level will intensify the market demand.

Key Restraints

Limited clinical statistics regarding the efficacy of dengue vaccines hamper the market growth.
High cost of dengue vaccines are making them unaffordable in poor countries limiting the market growth.
Fluctuation in government approval policies during manufacturing and distribution will negatively affects the market sales.

Competitive Landscape

The main area of focus among all market players is performing merger, acquisition, and strategic collaboration with leading pharmaceutical companies to expand their foothold.

They are also conducting rigorous clinical trials to develop multiple vaccines and drugs in prescription market.

Sanofi Pasteur has developed a tetravalent dengue vaccine called “Dengvaxia®” and is reported to be highly effective for preventing outbreaks resulting from all four dengue virus serotypes in preadolescents, adolescents and adults, aged 9 to 45 years. The vaccine was approved after an extensive clinical trials conducted in 15 countries.

Merck & Co. allied with Instituto Butantan, Sao Paulo, Brazil, in 2018. The collaboration aimed towards developing vaccines to protect against dengue virus. They are developing live attenuated tetravalent vaccines (LATV).

Takeda Pharmaceutical Company Limited launched its European Medicines Agency (EMA) approved, TAK-003 dengue vaccine in March 2021.

Leading players profiled by FMI operating in dengue vaccines market include

Sanofi Pasteur Limited
Takeda Pharmaceutical Company Limited
Merck & Co. Inc.
GlaxoSmithKline Plc.
GeneOne Life Science Inc.
Medigen Vaccine Biologics Corporation
Panacea Biotec Limited
Sun Pharmaceutical Industries Ltd
Serum Institute of India Pvt. Ltd.
Biological E Ltd.

Download Methodology of this Report @ https://www.futuremarketinsights.com/askus/rep-gb-1763

More Insights on FMI’s Dengue Vaccines Market

The latest market study on global dengue vaccines market by Future Market Insights gives a detailed segmentation for the forecast period of 2021-2031. In order to gain a better perspective of the global market potential, its growth, trends, and opportunities, the market is segmented on the basis of:

Product

CYD-TDV (Dengvaxia)

End-User

Hospitals
Government Institutes
Non-governmental Organizations (NGOs)

Region

North America (US and Canada)
Latin America (Brazil, Mexico, Venezuela and Rest of LATAM)
Western Europe (Germany, UK, France, Spain, Italy and Rest of Western Europe)
Eastern Europe (Russia, Poland and Rest of Eastern Europe)
APEJ (The Philippines, Indonesia, Malaysia, Thailand, Vietnam, India and Rest of APEJ)
Japan
Middle East & Africa (GCC, Northern Africa, South Africa and Rest of MEA)

Contact Info:
Name: Abhishek Budholiya
Email: Send Email
Organization: Future Market Insights
Website: https://www.futuremarketinsights.com/reports/dengue-vaccines-market

Source URL: https://marketersmedia.com/surge-in-dengue-fever-in-low-income-nations-creating-opportunities-for-expansion-of-dengue-vaccines-market-demand-fmi/89023932

Source: MarketersMedia

Release ID: 89023932

More News

Japanese volleyball player Ran Takahashi’s brother comes out as gay in rare case
Sep 29, 2026

Japanese volleyball player Ran Takahashi’s brother comes out as gay in rare case

TOKYO — Japanese volleyball player Rui Takahashi came out as gay on Tuesday, saying he wanted to help others struggling with their sexuality in a country where openly LGBTQ athletes are extremely rare. The 26-year-old Takahashi, who plays in the top division of Japan's professional volleyball league, posted a statement on social media accompanied by a black-and-white photo of himself. In it, he said he had been "afraid to face a certain side of myself" since he was young. "I struggled with it and ended up denying who I was," he wrote. "That is the fact that I am gay and that I am one of the sexual minorities." Takahashi said his brother Ran, who is a hugely popular star with Japan's national volleyball team, helped him come to terms with his sexuality. "Talking with Ran became the trigger that finally allowed me to accept myself for the first time," he wrote. "By putting my feelings into words, I was able to sort out my thoughts, and little by little I started to feel that it was OK to be just the way I am." Takahashi becomes one of a very small group of openly LGBTQ professional athletes in Japan. Women's football player Shiho Shimoyamada was the first to come out as gay in 2019. Kumi Yokoyama, who played for Japan at the Women's World Cup, later came out as a transgender man. In June 2021, the Japanese Olympic Committee appointed transgender former fencer Fumino Suhiyama to its board of directors, just weeks before the Tokyo Olympics. Takahashi said he hoped him coming out would help others in a similar situation. "I would be happy if my decision to face myself and speak in my own words could, even in a small way, become a catalyst for them," he wrote. AFP

Ababa grabs ICTSI Iloilo lead as Mondilla falters in wild opener
Sep 29, 2026

Ababa grabs ICTSI Iloilo lead as Mondilla falters in wild opener

MANILA, Philippines – Jhonnel Ababa kept his cool under a scorching sun and swirling winds, producing the only bogey-free round of the day to seize solo control of the ICTSI Iloilo Golf Challenge here on Wednesday. In one of the most tightly packed opening rounds in Philippine Golf Tour history, Ababa fired a three-under 67 at the Iloilo Golf and Country Club to emerge a stroke clear of a six-way logjam at second, where erstwhile leader Clyde Mondilla found himself after a late stumble. The leaderboard resembled a traffic jam for much of the day, with positions changing almost as quickly as the wind shifted direction. Five more players were bunched at 69, while six others stood just another shot back at 70 in the P2.5 million championship organized by Pilipinas Golf Tournaments, Inc. The heat was relentless, but it was the wind that proved the more persistent adversary, particularly on the back nine. On the short but tight layout, narrow fairways and thick rough left little margin for error, while the gusts made club selection and approach shots even more demanding. Ababa handled the conditions with characteristic composure. The Davaoeño ace birdied Nos. 6, 11 and 14, then relied on crisp iron play, steady putting and three key par saves to protect his lead down the stretch. He nearly made it four birdies when he reached the 18th but missed a three-foot putt that would have given him a four-under card and a two-shot cushion. Still, the bogey-free 67 gave him the distinction of being the only player in the field to go around without dropping a shot. “My driving and iron play were solid, and my putting clicked. You really have to hit straight here because the fairways are narrow – if you miss, the rough is quite deep,” said Ababa in Filipino. He also credited a timely break or two for helping him navigate the demanding conditions. “The course was extremely tough, especially when the wind picked up on the back nine. I focused on hitting greens in regulation, and whenever a birdie opportunity came up, I made the putt. I got a bit lucky today,” he said. Ababa, seeking redemption after contending for three days in Negros Occidental last week before fading in the final round and settling for third, showed none of that late-round slide this time. Instead, he leaned on the steadiness that has become his trademark, refusing to give away shots as the leaderboard repeatedly shuffled behind him. Mondilla appeared headed for the outright lead himself after reaching four-under with four holes to play. But the multi-titled campaigner missed the greens on Nos. 6 and 8, leaving himself lengthy par putts and eventually dropping both shots. “I missed the greens on holes 6 and 8, and my par putts were from a long distance,” rued Mondilla in Filipino, who had also shown encouraging form in Negros last week, finishing joint eighth after making five birdies against one bogey through 14 holes. His 68 nevertheless kept him firmly in contention, joining Paul Echavez, Reymon Jaraula, Miki Ryoma and Rupert Zaragosa in a five-way tie for second. Jeffren Lumbo, runner-up to Art Arbole in Negros last week, led the group at 69, alongside Randy Garalde, James Ryan Lam, Gerald Rosales, Guido van der Valk and Paul Vesinica. The volatility of the opening round was underscored by Arbole's own roller-coaster finish. Two-over after 15 holes, the reigning Negros champion suddenly found his footing with back-to-back birdies on Nos. 16 and 17, salvaging an even-par 70 and keeping himself within three strokes of Ababa. “It's a good thing I managed to bounce back. The layouts of Iloilo and Negros are quite similar. For me, the main difference was that the rough here is thicker and the greens are slower, but it was manageable,” said Arbole in Filipino. Arbole was tied for 13th with Taewon Ha, Tony Lascuña, Francis Morilla, Edmar Salvador Jr. and Lee Song. Also within striking distance at 71 were Ira Alido, Kristoffer Arevalo, Jerson Balasabas, Russell Bautista, Michael Bibat, Rico Depilo, Francis Mendez, Ryan Monsalvae and amateur Bobe Salahog. Reigning Order of Merit champion and two-leg winner Angelo Que, meanwhile, settled for a 74 and a share of 28th with Jay Bayron, Elee Bisera, Carlos Packing, Enrico Gallardo and Justin Quiban. With only three shots separating Ababa from a large group of pursuers, little was settled in the opening round. If Tuesday was any indication, the Iloilo challenge is likely to be decided not by one spectacular charge but by who can withstand the heat, tame the wind and avoid the costly lapse when the pressure mounts. For one day, at least, Ababa proved the field's steadiest hand. TMT

Last man standing Carlo Paalam faces Kazakh rival to keep PH gold dream alive
Sep 29, 2026

Last man standing Carlo Paalam faces Kazakh rival to keep PH gold dream alive

MANILA, Philippines — Tokyo Olympic silver medalist Carlo Paalam carries the country's hopes on his shoulders as the sole remaining boxer for the Philippines at the 2026 Asian Games, aiming to break a 16-year gold medal drought. The Philippines has not captured Asian Games boxing gold since Rey Saludar stood atop the podium in Guangzhou in 2010. Following years of bronze finishes and near-misses across Incheon, Jakarta-Palembang, and Hangzhou, Paalam now stands just two wins away from ending the dry spell. Paalam secured his spot in the medal round at the Nishio Gymnasium after outpointing China's Jiamao Zhang in the quarterfinals. The victory guarantees him at least a bronze medal, but standing between him and a spot in the gold medal match is Kazakhstan's Makhmud Sabyrkhan. The upcoming semifinal is a high-stakes rematch four years in the making. The two fighters last met in the bantamweight final of the 2022 ASBC Asian Elite Boxing Championships in Amman, Jordan, where Paalam edged out Sabyrkhan via a 4-1 split decision to take gold. However, Sabyrkhan enters the ring as a vastly matured competitor. Since their last encounter, the Kazakh star has established himself as a two-time world champion—securing silver at the 2021 AIBA World Championships and gold at the 2023 IBA World Championships. After competing at 57kg in the 2024 Paris Olympics, Sabyrkhan returned to his natural 55kg weight class to dominate the 2025 WB World Boxing Championships, earning him World Boxing's Best Boxer of 2025 honors. While Sabyrkhan seeks redemption, Paalam fights to secure a guaranteed silver and keep the nation's quest for Asian Games gold alive. TMT

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.